Sivik Global Healthcare LLC lifted its stake in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 33.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 200,000 shares of the health services provider's stock after acquiring an additional 50,000 shares during the quarter. Select Medical accounts for 1.8% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 25th largest position. Sivik Global Healthcare LLC owned 0.16% of Select Medical worth $3,340,000 as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC grew its holdings in Select Medical by 151.0% during the 1st quarter. SG Americas Securities LLC now owns 37,684 shares of the health services provider's stock worth $629,000 after acquiring an additional 22,671 shares in the last quarter. Ritholtz Wealth Management purchased a new stake in shares of Select Medical in the first quarter valued at about $460,000. American Century Companies Inc. boosted its position in shares of Select Medical by 1,309.5% during the 4th quarter. American Century Companies Inc. now owns 137,169 shares of the health services provider's stock worth $2,586,000 after purchasing an additional 127,437 shares in the last quarter. Sanctuary Advisors LLC grew its position in Select Medical by 122.8% during the fourth quarter. Sanctuary Advisors LLC now owns 52,175 shares of the health services provider's stock worth $1,035,000 after buying an additional 28,759 shares during the period. Finally, Sterling Capital Management LLC increased its position in Select Medical by 9.5% during the fourth quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider's stock worth $213,000 after buying an additional 978 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have commented on SEM shares. Mizuho started coverage on shares of Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price for the company. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research note on Monday, February 24th. Finally, Royal Bank Of Canada decreased their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 7th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $26.00.
Read Our Latest Stock Analysis on SEM
Insider Buying and Selling
In other Select Medical news, Director Parvinderjit S. Khanuja bought 21,000 shares of the company's stock in a transaction dated Monday, May 5th. The shares were bought at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the acquisition, the director now directly owns 65,089 shares of the company's stock, valued at approximately $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the sale, the chief executive officer now owns 714,516 shares of the company's stock, valued at approximately $12,861,288. This represents a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by company insiders.
Select Medical Stock Up 1.4%
Shares of SEM traded up $0.21 during mid-day trading on Tuesday, reaching $15.10. 1,162,029 shares of the stock traded hands, compared to its average volume of 973,372. The firm has a market cap of $1.94 billion, a price-to-earnings ratio of 11.27, a P/E/G ratio of 0.79 and a beta of 1.34. The stock has a fifty day simple moving average of $15.47 and a 200 day simple moving average of $17.31. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.87. Select Medical Holdings Corporation has a 12-month low of $14.03 and a 12-month high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The company's revenue for the quarter was down 24.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.75 EPS. Sell-side analysts expect that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.
Select Medical Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.66%. The ex-dividend date of this dividend was Thursday, May 15th. Select Medical's payout ratio is currently 18.66%.
Select Medical declared that its board has authorized a share repurchase plan on Thursday, May 1st that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to reacquire up to 42.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's management believes its shares are undervalued.
Select Medical Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report